from Reuters: Business News http://ift.tt/2EkCoQu
Monday 29 January 2018
How Sanofi's setback could lead to better dengue vaccines
CHICAGO (Reuters) - New dengue vaccines being developed by Takeda Pharmaceuticals Co Ltd and U.S. government scientists are poised to provide a safer alternative to Sanofi's Dengvaxia, according to vaccine experts, because they already take into account some of the issues that sidelined the product last year.
from Reuters: Business News http://ift.tt/2EkCoQu
from Reuters: Business News http://ift.tt/2EkCoQu
Subscribe to:
Post Comments (Atom)
3 reasons rate cuts won't stimulate the economy like they have in the past: Morgan Stanley Wealth Management CIO
Reuters The Fed has started cutting rates, but it's not likely to boost the economy much, Lisa Shalett says. The economy is less ...
-
Before investing your own money into a small business idea, test it out with your target audience. Georgijevic/Getty Images Having a bu...
-
Stocks could crash nearly 50% and a recession might hit this year, B. Riley's Paul Dietrich said. Yuichiro Chino/Getty Images The S...
-
The benchmark S&P 500 index just logged its longest losing streak of 2023, per data from Refinitiv. Mario Tama / Getty US stocks...
No comments:
Post a Comment